Japan Insulin Infusion Pump Market Size (2024 - 2029)

The Japan insulin infusion pump market is anticipated to experience growth over the forecast period, driven by factors such as the country's aging population and increasing diabetes incidence linked to lifestyle changes. The market size is influenced by the rising number of diabetes diagnoses, particularly through metabolic syndrome screenings, which have become more prevalent in addressing lifestyle-related health issues. Despite the growing need, the penetration of insulin pumps among type 1 diabetes patients remains limited, indicating potential for market expansion.

Home Market Analysis Healthcare Research Medical Devices Research Japan Insulin Infusion Pump Market Market Size

Market Size of Japan Insulin Infusion Pump Industry

Japan Insulin Infusion Pump Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Historical Data Period 2019 - 2022
CAGR 4.10 %

Major Players

Japan Insulin Infusion Pump Market Major Players

*Disclaimer: Major Players sorted in no particular order

Japan Insulin Infusion Pump Market Analysis

Japan Insulin Infusion Pumps Market is expected to register a CAGR of more than 4.1% and reach a value of about USD 65.72 million over the forecast period.

The number of Japanese casualties of the COVID-19 pandemic was lower than that of other countries, which might be attributed to genetic variances, aspects of Japanese culture, and differences in the coagulation system between Japanese and Caucasians. In order to alleviate hospital overcrowding, the Osaka Prefectural Government classified patients as mild, moderate, or severe and assigned them to different alternative lodgings. In compliance with national government rules, hospitals offer patient care. Individuals with intermediate conditions, or those with adequate oxygen saturation readings despite the presence of symptoms on computed tomography, are being targeted. In contrast to Type 1 diabetes, which is caused by immune system failure, Type 2 diabetes is connected to a sedentary lifestyle, which promotes the development of intrinsic insulin resistance.

Japan's aging population, which is more vulnerable to illness, as well as an increase in obesity caused by inactivity and irregular eating patterns, are thought to be contributing causes to the country's growing diabetes incidence. More people have been diagnosed with the condition as a result of being sent to a medical institution based on the findings of the metabolic syndrome screening, which was established in 2008 to avoid lifestyle-related ailments. Diabetes incidence in Japan is expected to rise much further as the population ages. The number of Japanese individuals with type 1 diabetes is estimated to be 100,000-140,000, accounting for 0.09-0.1% of the total population. The number of insulin pump users among Japanese patients with type 1 diabetes mellitus is believed to be around 10,000, implying that the insulin pump has not yet overrun Japan.

Japan Insulin Infusion Pump Industry Segmentation

An insulin pump is used to deliver insulin to achieve proper blood sugar control and minimize hypoglycemia's effects. The pump is composed of a pump reservoir like an insulin cartridge, a battery-operated pump, and a computer chip that allows the user to control the exact amount of insulin being delivered. The pump is attached to a thin plastic tube (an infusion set) with a soft cannula (or needle) at the end through which insulin passes. Japan's insulin infusion pumps market is segmented by component (pump device, infusion set, and reservoir). The report offers the value (in USD million) and Volume (in units Million) for the above segments.

Insulin Infusion Pump
Insulin Pump Device
Infusion Set
Reservoir
Need A Different Region Or Segment?
Customize Now

Japan Insulin Infusion Pump Market Size Summary

The Japan insulin infusion pump market is poised for steady growth, driven by the increasing prevalence of diabetes, particularly type 1 and type 2, among the aging population and those with sedentary lifestyles. The market is characterized by the adoption of advanced insulin delivery systems, which offer more precise and less painful alternatives to traditional injection methods. Insulin pumps, which mimic the pancreas's natural insulin delivery, are becoming more popular due to their ability to maintain stable blood glucose levels and improve the quality of life for diabetes patients. Despite the benefits, the penetration of insulin pumps in Japan remains limited, with a relatively small number of users compared to the total diabetes population, indicating significant growth potential.

The market landscape is dominated by a few key players, both international and local, such as Medtronic PLC, Insulet Corporation, Ypsomed, Ascensia Diabetes Care, and Tandem Diabetes Care. These companies are actively involved in strategic initiatives, including acquisitions and product launches, to enhance their market presence and expand their product offerings. The competitive environment is shaped by the need for innovation and the integration of continuous glucose monitoring systems with insulin pumps, which are expected to drive market expansion. However, challenges such as dietary changes, lack of standardized diabetes education, and delayed treatment post-screening continue to impact the market's growth trajectory.

Explore More

Japan Insulin Infusion Pump Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

    3. 1.3 Market Restraints

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Bargaining Power of Suppliers

      2. 1.4.2 Bargaining Power of Consumers

      3. 1.4.3 Threat of New Entrants

      4. 1.4.4 Threat of Substitute Products and Services

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 Insulin Infusion Pump

      1. 2.1.1 Insulin Pump Device

      2. 2.1.2 Infusion Set

      3. 2.1.3 Reservoir

Japan Insulin Infusion Pump Market Size FAQs

The Japan Insulin Infusion Pump Market is projected to register a CAGR of greater than 4.10% during the forecast period (2024-2029)

Medtronics, Ascensia Diabetes Care, Insulet Corporation, Tandem Diabetes Care and Ypsomped are the major companies operating in the Japan Insulin Infusion Pump Market.

Japan Insulin Infusion Pump Market Report Snapshots

Japan Insulin Infusion Pump Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)